Physician profile
Drew Turner
NPI 1598185084
$1,600.65
in general payments reported to CMS, 2019-2025
21 companies · $459 in 2025
The $459 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.79 · 2020: $51.33 · 2021: $36.32 · 2022: $183 · 2023: $371 · 2024: $473 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,301.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $416.77 | 2023-2025 | Gattex, Eohilia |
| Smith+Nephew, INC. | $260.73 | 2023-2025 | Collagenase Santyl, Grafix Pl, Renasys Touch |
| Davol INC. | $110.90 | 2022-2025 | Arista |
| Csl Behring | $102.85 | 2021-2023 | Kcentra |
| Solventum Corporation | $85.49 | 2024-2025 | Activ.A.C., V.A.C. Veraflo, Prevena |
| Acera Surgical, INC. | $84.19 | 2023-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $78.42 | 2024-2025 | Ligasure, Sonicision |
| Alexion Pharmaceuticals, INC. | $71.29 | 2022 | |
| Tela Bio, INC. | $54.16 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $51.89 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $47.93 | 2023 | Andexxa |
| Kerecis Limited | $41.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sanara Medtech INC. | $27.94 | 2024 | Celleraterx |
| Teleflex LLC | $27.79 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.40 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $24.60 | 2023 | Exparel |
| Portola Pharmaceuticals, LLC | $23.00 | 2020 | |
| Kci USA, INC. | $19.55 | 2022 | |
| Convatec INC. | $17.68 | 2023 | |
| Allergan, INC. | $16.05 | 2020 | |
| Integra Lifesciences Corporation | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.